Aspiration pneumonia in post-stroke patients showed significantly increased 90-day mortality, longer hospital stays, and more ...

Acute ischemic stroke, which occurs due to a blockage in cerebral blood flow, requires prompt intervention with thrombolytic ...

The US Patent and Trademark Office (USPTO) has allowed two new patents for Remedy Pharmaceuticals’ Cirara, aimed at treating ...

The National Institutes of Health Stroke Scale (NIHSS) is accepted as the definitive clinical examination to assess stroke severity. This project examined barriers to implementation and NIHSS use ...

Remedy Pharmaceuticals, a leader in stroke drug development, today announced that the U.S. Patent and Trademark Office (USPTO) has allowed two additional patents covering its large hemispheric ...

Hence, the NIHSS may underestimate stroke severity in the right hemisphere (Woo et al., 1999). In addition, although many components of the NIHSS are part of a standard neurological assessment ...

medical comorbidities), admission National Institutes of Health Stroke Scores (NIHSS), stroke severity, disposition and 90-day outcomes were prospectively obtained. Stroke severity was determined by ...

Because of the importance of stroke severity in evaluating these short‐term AIS outcomes, we conducted regression models separately for all admissions and the subset of admissions with available NIHSS ...

Clinical data: admission time, neurological examination results, complications. The severity of stroke was assessed using the NIHSS (National Institute of Health Strokes Scale). Paraclinical data: ...

Basic demographic data, vascular risk factors, stroke severity (National Institute of Health Stroke Scale; NIHSS), pre-stroke cognitive decline (Informant Questionnaire on Cognitive Decline in the ...